GlassScriptPhysician profile
Grace Langholz
NPI 1043850431
$1,759.05
in general payments reported to CMS, 2019-2025
19 companies · $52.79 in 2025
The $52.79 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $46.87 · 2022: $373 · 2023: $492 · 2024: $795 · 2025: $52.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,339.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $573.07 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $391.84 | 2022-2024 | Xifaxan, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $141.31 | 2022-2024 | Entyvio, Eohilia |
| Ardelyx, INC. | $98.91 | 2022-2023 | Ibsrela |
| Merck Sharp & Dohme LLC | $77.63 | 2023-2024 | Dificid |
| Qol Medical, LLC | $70.00 | 2022-2024 | Sucraid, Sucraid |
| Genentech USA, INC. | $58.93 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $56.95 | 2022-2024 | Dupixent |
| Janssen Biotech, INC. | $51.45 | 2022 | |
| Pfizer INC. | $49.24 | 2024 | |
| Madrigal Pharmaceuticals | $38.91 | 2024 | Resmetirom |
| Celgene Corporation | $29.63 | 2024 | Zeposia |
| E.R. Squibb & Sons, L.L.C. | $22.04 | 2023 | Zeposia |
| Daiichi Sankyo INC. | $19.42 | 2022 | |
| Genzyme Corporation | $18.03 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $16.80 | 2022 | |
| Intercept Pharmaceuticals, INC. | $15.86 | 2022 | |
| Aimmune Therapeutics, INC. | $14.77 | 2025 | Zenpep |
| Nestle Healthcare Nutrition INC. | $14.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Langholz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.